Clinical Trials Logo

Clinical Trial Summary

Hysterectomy is an effective treatment used as a first-line approach for uterine myomas. Several others alternatives to hysterectomy have been developed in recent years for women wishing to retain their uterus: myomectomy, radiological embolization, focused ultrasound.

Myomectomy, particularly through minimally invasive surgery, is currently considered the conservative treatment of choice for patients wishing to preserve their fertility. However, three important issues should be considered: the risk of intra- and postoperative bleeding, the risk for recurring myomas, and the preservation of subsequent fertility.

Preventive uterine artery occlusion can be combined with laparoscopic myomectomy in order to avoid bleeding and improve uterine suture. Another expected long-term benefit is the improvement of treatment efficacy, leading to less symptoms and myomas recurrence. However, the effect of uterine arteries occlusion on the ovarian reserve of women of childbearing age has not yet been studied, which limits its clinical application.


Clinical Trial Description

Objectives:

1. To assess the effect of preventive uterine artery occlusion during laparoscopic myomectomy on ovarian reserve parameters;

2. To evaluate the effect of preventive uterine artery occlusion during laparoscopic myomectomy on intra- and postoperative blood loss, operative time, clinical symptoms improvement, long-term recurrence of myomas and fertility.

Materials and methods:

Design: This is a prospective randomized single blind trial, including 60 women undergoing a laparoscopic myomectomy for symptomatic uterine myomas. Patients are randomized into two groups: a control group "myomectomy alone" and an experimental group "myomectomy with preventive uterine arteries occlusion".

Setting: The duration of the study will normally be 5 years and will take place at the University Hospitals of Geneva. The study will include about 20 women per year and follow-up will last 2 years. Inclusion criteria are: women of childbearing age, wishing to retain their uterus, having symptomatic uterine myomas and who are eligible for a laparoscopic myomectomy.

The parameters that will be intraoperatively evaluated are the operation time, blood loss and the complications of the surgical technique. Postoperative complications, improving clinical symptoms, myomas recurrence and fertility are discussed at short and long term follow-up.

The ovarian reserve will be evaluated pre- and postoperatively for each patient. It will be determined by plasmatic AMH (anti-Mullerian Hormone) and ultrasound antral follicle count. Women with undetectable preoperative plasmatic AMH will be excluded from the study. Plasmatic AMH and antral follicle count will be measured at 1, 3, 6, 12 and 24 months during the postoperative follow-up.

Limitations:

The sample size is calculated in order to demonstrate a significant difference in plasmatic AMH before and after myomectomy. Small differences are not highlighted in this study, but they probably would not have any impact in clinical practice.

Impact of the study:

The results of this study could have a real impact on daily surgical practice. In case of persistent alteration of ovarian reserve in the experimental group compared to the control group, preventive uterine arteries occlusion during a laparoscopic myomectomy should only be indicated in patients who do not wish pregnancy. If there is no significant impact on ovarian reserve and a beneficial effect on reducing intraoperative blood loss and long-term improvement of symptoms, it should be systematically proposed in all patients undergoing a laparoscopic myomectomy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02563392
Study type Interventional
Source University Hospital, Geneva
Contact Lauriane Ramyead, Dre
Email lauriane.ramyead@hcuge.ch
Status Recruiting
Phase N/A
Start date April 2015
Completion date May 2024

See also
  Status Clinical Trial Phase
Completed NCT01937104 - ONSD According to the Position During Laparoscopy N/A
Completed NCT01984632 - Barbed Suture in Single-port Laparoscopic Myomectomy Phase 3
Completed NCT01492179 - Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. Phase 4
Recruiting NCT06099977 - Binaural Sound for Remimazolam Induction N/A
Completed NCT05086770 - Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere N/A
Withdrawn NCT03156127 - A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet Phase 1
Completed NCT05108597 - Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy Phase 3
Completed NCT02392585 - Single or Triple Uterine Tourniquet at Myomectomy N/A
Completed NCT02086435 - Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety Outcomes N/A
Completed NCT01379313 - The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position N/A
Completed NCT04279626 - Surgical Outcome of Two-port Laparoscopic Myomectomy
Completed NCT01873378 - GnRH Agonist Pretreatment in Hysteroscopic Myomectomy N/A
Completed NCT01064128 - Study of Different Pain Scores in Single-Port Access (SPA) Laparoscopic Hysterectomy Versus Conventional Laparoscopic Hysterectomy Phase 3
Recruiting NCT01267851 - Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Completed NCT01542658 - Comparison of Robot-assisted Laparoscopic Myomectomy With Traditional Laparoscopic Myomectomy N/A
Recruiting NCT02631278 - Radio Frequency Ablation (RFA STUDY ) N/A
Recruiting NCT01637974 - Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery N/A
Recruiting NCT01483417 - Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy Phase 3
Completed NCT02056717 - Use of Dexamethasone in Uterine Artery Embolization N/A